NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1349326426|gb|PPX92014|]
View 

hypothetical protein C3D72_09045 [Cronobacter sakazakii]

Protein Classification

fructosamine kinase family protein( domain architecture ID 10511147)

fructosamine kinase family protein such as protein-ribulosamine 3-kinase, which catalyzes the phosphorylation of protein-bound ribulosamines that become unstable as a consequence and detach from proteins

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
Fructosamin_kin pfam03881
Fructosamine kinase; This family includes eukaryotic fructosamine-3-kinase enzymes. The family ...
1-284 1.33e-158

Fructosamine kinase; This family includes eukaryotic fructosamine-3-kinase enzymes. The family also includes bacterial members that have not been characterized but probably have a similar or identical function.


:

Pssm-ID: 427564 [Multi-domain]  Cd Length: 288  Bit Score: 442.84  E-value: 1.33e-158
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426   1 MWHAITRLLNEQLGAG-EISQRTELPGGEIHAAWRIDWAGRAIFVKCDDSTLLPCFTAEADQLILLARSKTVTVPEVLGV 79
Cdd:pfam03881   1 MWQAIAQQLSEQTGKPfEITEREPVGGGDINQAYRLSDGEQRYFVKLNQREQLAMFEAEAEGLEALAETQTIRVPKVIAW 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426  80 GSDREYSFLLLEYLPPKPLDAHNAFLLGQQLARLHQWSEQPQYGLDYDNHLSTTPQPNAWQRRWASFFAEQRIGWQLELA 159
Cdd:pfam03881  81 GSSRDHSFLVLEYLELGPDNRGSAYELGQQLAKLHRWSGQKQFGFDFDNTIGSTPQPNTWQSSWADFFAEQRIGWQLQLA 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426 160 AEKGMEFGDIDRIVDAVHQQLVSHQPAPSLLHGDLWSGNCALGPDG-PYIFDPACYWGDRECDLAMLPLHPEQPPQIYDG 238
Cdd:pfam03881 161 KEKGGNFGNIDRLVERVADLLAGHQPQPSLLHGDLWSGNAAFTADGePVIFDPACYYGDRECDLAMTELFGGFPPSFYEG 240
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|....*.
gi 1349326426 239 YQSVLPLPAGFLERQPLYQLYTLLNRATLFGGQHLVAAQQALTRVL 284
Cdd:pfam03881 241 YQSVWPLDEGYEDRKPLYQLYHLLNHLNLFGGGYLSQAQQLIDKLL 286
 
Name Accession Description Interval E-value
Fructosamin_kin pfam03881
Fructosamine kinase; This family includes eukaryotic fructosamine-3-kinase enzymes. The family ...
1-284 1.33e-158

Fructosamine kinase; This family includes eukaryotic fructosamine-3-kinase enzymes. The family also includes bacterial members that have not been characterized but probably have a similar or identical function.


Pssm-ID: 427564 [Multi-domain]  Cd Length: 288  Bit Score: 442.84  E-value: 1.33e-158
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426   1 MWHAITRLLNEQLGAG-EISQRTELPGGEIHAAWRIDWAGRAIFVKCDDSTLLPCFTAEADQLILLARSKTVTVPEVLGV 79
Cdd:pfam03881   1 MWQAIAQQLSEQTGKPfEITEREPVGGGDINQAYRLSDGEQRYFVKLNQREQLAMFEAEAEGLEALAETQTIRVPKVIAW 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426  80 GSDREYSFLLLEYLPPKPLDAHNAFLLGQQLARLHQWSEQPQYGLDYDNHLSTTPQPNAWQRRWASFFAEQRIGWQLELA 159
Cdd:pfam03881  81 GSSRDHSFLVLEYLELGPDNRGSAYELGQQLAKLHRWSGQKQFGFDFDNTIGSTPQPNTWQSSWADFFAEQRIGWQLQLA 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426 160 AEKGMEFGDIDRIVDAVHQQLVSHQPAPSLLHGDLWSGNCALGPDG-PYIFDPACYWGDRECDLAMLPLHPEQPPQIYDG 238
Cdd:pfam03881 161 KEKGGNFGNIDRLVERVADLLAGHQPQPSLLHGDLWSGNAAFTADGePVIFDPACYYGDRECDLAMTELFGGFPPSFYEG 240
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|....*.
gi 1349326426 239 YQSVLPLPAGFLERQPLYQLYTLLNRATLFGGQHLVAAQQALTRVL 284
Cdd:pfam03881 241 YQSVWPLDEGYEDRKPLYQLYHLLNHLNLFGGGYLSQAQQLIDKLL 286
FN3K COG3001
Fructosamine-3-kinase [Carbohydrate transport and metabolism];
3-284 3.41e-137

Fructosamine-3-kinase [Carbohydrate transport and metabolism];


Pssm-ID: 442239 [Multi-domain]  Cd Length: 287  Bit Score: 388.79  E-value: 3.41e-137
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426   3 HAITRLLNEQLGAG-EISQRTELPGGEIHAAWRIDWAGRAIFVKCDDSTLLPCFTAEADQLILLARSKTVTVPEVLGVGS 81
Cdd:COG3001     1 QAIAEALSEALGPPfEITSVRPVSGGDINQAYRVTTDGRRVFVKLNPASPLGMFEAEAAGLRALAATGTIRVPEVIGVGT 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426  82 DREYSFLLLEYLPPKPLDAHNAFLLGQQLARLHQWSeQPQYGLDYDNHLSTTPQPNAWQRRWASFFAEQRIGWQLELAAE 161
Cdd:COG3001    81 TGDHAFLVLEYLELGPPTAGAWERLGRQLAALHQAT-APRFGWDRDNFIGSTPQPNTWTDDWAEFFAEQRLGPQLQLAAE 159
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426 162 KGMEFG----DIDRIVDAVHQQLVSHQPAPSLLHGDLWSGNCALGPDG-PYIFDPACYWGDRECDLAMLPLHPEQPPQIY 236
Cdd:COG3001   160 KGLLFAadreRIERLVERLPELLAPHEPQPSLLHGDLWSGNVLFTADGePVLIDPAVYYGDREVDLAMTELFGGFPDAFY 239
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|....*...
gi 1349326426 237 DGYQSVLPLPAGFLERQPLYQLYTLLNRATLFGGQHLVAAQQALTRVL 284
Cdd:COG3001   240 DAYQEVWPLDPGYEERKPLYQLYHLLNHLNLFGGSYLSQAERILDRLL 287
ACAD10_11_N-like cd05154
N-terminal domain of Acyl-CoA dehydrogenase (ACAD) 10 and 11, and similar proteins; This ...
22-259 2.31e-07

N-terminal domain of Acyl-CoA dehydrogenase (ACAD) 10 and 11, and similar proteins; This subfamily is composed of the N-terminal domains of vertebrate ACAD10 and ACAD11, and similar uncharacterized bacterial and eukaryotic proteins. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 are both significantly expressed in human brain tissues. They contain a long N-terminal domain with similarity to phosphotransferases with a Protein Kinase fold, which is absent in other ACADs. They may exhibit multiple functions in acyl-CoA oxidation pathways. ACAD11 utilizes substrates with carbon chain lengths of 20 to 26, with optimal activity towards C22CoA. ACAD10 may be associated with an increased risk in type II diabetes. The ACAD10/11-like subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K).


Pssm-ID: 270703 [Multi-domain]  Cd Length: 254  Bit Score: 50.69  E-value: 2.31e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426  22 TELPGGEIHAAWRIDWAG-----RAIFVKCDDSTLLPCFTA---EAdQLILLARSKTVTVPEVLGVGSDREY---SFLLL 90
Cdd:cd05154     4 RRLSGGASNETYLVDAGGdgggrRLVLRRPPPGGLLPSAHDlerEY-RVLRALAGTGVPVPRVLALCEDPSVlgaPFYVM 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426  91 EYL----PPKPLDAHN---------AFLLGQQLARLHQwseqpqygLDYDNH--LSTTPQPNAWQR---RWASFFAEQRi 152
Cdd:cd05154    83 ERVdgrvLPDPLPRPDlspeerralARSLVDALAALHS--------VDPAALglADLGRPEGYLERqvdRWRRQLEAAA- 153
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426 153 gwqlelaaekgmefGDIDRIVDAVHQQLVSHQPA---PSLLHGDLWSGNCalgpdgpyIFDPA-----------CYWGDR 218
Cdd:cd05154   154 --------------TDPPPALEEALRWLRANLPAdgrPVLVHGDFRLGNL--------LFDPDgrvtavldwelATLGDP 211
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|.
gi 1349326426 219 ECDLAMLpLHPEQPPQIYDGYQSVLPLPaGFLERQPLYQLY 259
Cdd:cd05154   212 LEDLAWL-LARWWRPGDPPGLAAPTRLP-GFPSREELLARY 250
 
Name Accession Description Interval E-value
Fructosamin_kin pfam03881
Fructosamine kinase; This family includes eukaryotic fructosamine-3-kinase enzymes. The family ...
1-284 1.33e-158

Fructosamine kinase; This family includes eukaryotic fructosamine-3-kinase enzymes. The family also includes bacterial members that have not been characterized but probably have a similar or identical function.


Pssm-ID: 427564 [Multi-domain]  Cd Length: 288  Bit Score: 442.84  E-value: 1.33e-158
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426   1 MWHAITRLLNEQLGAG-EISQRTELPGGEIHAAWRIDWAGRAIFVKCDDSTLLPCFTAEADQLILLARSKTVTVPEVLGV 79
Cdd:pfam03881   1 MWQAIAQQLSEQTGKPfEITEREPVGGGDINQAYRLSDGEQRYFVKLNQREQLAMFEAEAEGLEALAETQTIRVPKVIAW 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426  80 GSDREYSFLLLEYLPPKPLDAHNAFLLGQQLARLHQWSEQPQYGLDYDNHLSTTPQPNAWQRRWASFFAEQRIGWQLELA 159
Cdd:pfam03881  81 GSSRDHSFLVLEYLELGPDNRGSAYELGQQLAKLHRWSGQKQFGFDFDNTIGSTPQPNTWQSSWADFFAEQRIGWQLQLA 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426 160 AEKGMEFGDIDRIVDAVHQQLVSHQPAPSLLHGDLWSGNCALGPDG-PYIFDPACYWGDRECDLAMLPLHPEQPPQIYDG 238
Cdd:pfam03881 161 KEKGGNFGNIDRLVERVADLLAGHQPQPSLLHGDLWSGNAAFTADGePVIFDPACYYGDRECDLAMTELFGGFPPSFYEG 240
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|....*.
gi 1349326426 239 YQSVLPLPAGFLERQPLYQLYTLLNRATLFGGQHLVAAQQALTRVL 284
Cdd:pfam03881 241 YQSVWPLDEGYEDRKPLYQLYHLLNHLNLFGGGYLSQAQQLIDKLL 286
FN3K COG3001
Fructosamine-3-kinase [Carbohydrate transport and metabolism];
3-284 3.41e-137

Fructosamine-3-kinase [Carbohydrate transport and metabolism];


Pssm-ID: 442239 [Multi-domain]  Cd Length: 287  Bit Score: 388.79  E-value: 3.41e-137
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426   3 HAITRLLNEQLGAG-EISQRTELPGGEIHAAWRIDWAGRAIFVKCDDSTLLPCFTAEADQLILLARSKTVTVPEVLGVGS 81
Cdd:COG3001     1 QAIAEALSEALGPPfEITSVRPVSGGDINQAYRVTTDGRRVFVKLNPASPLGMFEAEAAGLRALAATGTIRVPEVIGVGT 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426  82 DREYSFLLLEYLPPKPLDAHNAFLLGQQLARLHQWSeQPQYGLDYDNHLSTTPQPNAWQRRWASFFAEQRIGWQLELAAE 161
Cdd:COG3001    81 TGDHAFLVLEYLELGPPTAGAWERLGRQLAALHQAT-APRFGWDRDNFIGSTPQPNTWTDDWAEFFAEQRLGPQLQLAAE 159
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426 162 KGMEFG----DIDRIVDAVHQQLVSHQPAPSLLHGDLWSGNCALGPDG-PYIFDPACYWGDRECDLAMLPLHPEQPPQIY 236
Cdd:COG3001   160 KGLLFAadreRIERLVERLPELLAPHEPQPSLLHGDLWSGNVLFTADGePVLIDPAVYYGDREVDLAMTELFGGFPDAFY 239
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|....*...
gi 1349326426 237 DGYQSVLPLPAGFLERQPLYQLYTLLNRATLFGGQHLVAAQQALTRVL 284
Cdd:COG3001   240 DAYQEVWPLDPGYEERKPLYQLYHLLNHLNLFGGSYLSQAERILDRLL 287
YcbJ COG3173
Predicted kinase, aminoglycoside phosphotransferase (APT) family [General function prediction ...
4-243 1.98e-17

Predicted kinase, aminoglycoside phosphotransferase (APT) family [General function prediction only];


Pssm-ID: 442406 [Multi-domain]  Cd Length: 284  Bit Score: 80.16  E-value: 1.98e-17
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426   4 AITRLLNEQL-GAGEISQRTELPGGEIHAAWRIDWAGRAIfVKCDDSTL--LPCFTAEADQLILLARSKTVTVPEVLGVG 80
Cdd:COG3173     7 ALRALLAAQLpGLAGLPEVEPLSGGWSNLTYRLDTGDRLV-LRRPPRGLasAHDVRREARVLRALAPRLGVPVPRPLALG 85
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426  81 SDRE---YSFLLLEYLPPKPLD-----------AHNAFLLGQQLARLHQwSEQPQYGLDYDNHLSTTPQPNAWQRRWASF 146
Cdd:COG3173    86 EDGEvigAPFYVMEWVEGETLEdalpdlspaerRALARALGEFLAALHA-VDPAAAGLADGRPEGLERQLARWRAQLRRA 164
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426 147 FAEQRigwqlelaaekgmefgDIDRIVDAVHQQLVSHQPA---PSLLHGDLWSGNCALGPDGPYI-----FDPACyWGDR 218
Cdd:COG3173   165 LARTD----------------DLPALRERLAAWLAANLPEwgpPVLVHGDLRPGNLLVDPDDGRLtavidWELAT-LGDP 227
                         250       260
                  ....*....|....*....|....*
gi 1349326426 219 ECDLAMLPLHPEQPPQIYDGYQSVL 243
Cdd:COG3173   228 AADLAYLLLYWRLPDDLLGPRAAFL 252
APH pfam01636
Phosphotransferase enzyme family; This family consists of bacterial antibiotic resistance ...
22-225 2.16e-15

Phosphotransferase enzyme family; This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881.


Pssm-ID: 426359 [Multi-domain]  Cd Length: 239  Bit Score: 73.69  E-value: 2.16e-15
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426  22 TELPGGEIHAAW-RIDWAGRAIFVKCDDSTLLPCFTAEADQLILLARSKTVTVPEVLGVGSDREYS---FLLLEYLPPKP 97
Cdd:pfam01636   3 RPISSGASNRTYlVTTGDGRYVLRLPPPGRAAEELRRELALLRHLAAAGVPPVPRVLAGCTDAELLglpFLLMEYLPGEV 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426  98 LDAHN--------AFLLGQQLARLHQwseqpqygldydnhLSTTPQPNAWQRRWASFFAEQRIGWQLELAAEK-GMEFGD 168
Cdd:pfam01636  83 LARPLlpeergalLEALGRALARLHA--------------VDPAALPLAGRLARLLELLRQLEAALARLLAAElLDRLEE 148
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1349326426 169 IDRIVDAVHQQLVSHQPAPSLLHGDLWSGNCALGPDGPYI----FDPACyWGDRECDLAML 225
Cdd:pfam01636 149 LEERLLAALLALLPAELPPVLVHGDLHPGNLLVDPGGRVSgvidFEDAG-LGDPAYDLAIL 208
ACAD10_11_N-like cd05154
N-terminal domain of Acyl-CoA dehydrogenase (ACAD) 10 and 11, and similar proteins; This ...
22-259 2.31e-07

N-terminal domain of Acyl-CoA dehydrogenase (ACAD) 10 and 11, and similar proteins; This subfamily is composed of the N-terminal domains of vertebrate ACAD10 and ACAD11, and similar uncharacterized bacterial and eukaryotic proteins. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 are both significantly expressed in human brain tissues. They contain a long N-terminal domain with similarity to phosphotransferases with a Protein Kinase fold, which is absent in other ACADs. They may exhibit multiple functions in acyl-CoA oxidation pathways. ACAD11 utilizes substrates with carbon chain lengths of 20 to 26, with optimal activity towards C22CoA. ACAD10 may be associated with an increased risk in type II diabetes. The ACAD10/11-like subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K).


Pssm-ID: 270703 [Multi-domain]  Cd Length: 254  Bit Score: 50.69  E-value: 2.31e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426  22 TELPGGEIHAAWRIDWAG-----RAIFVKCDDSTLLPCFTA---EAdQLILLARSKTVTVPEVLGVGSDREY---SFLLL 90
Cdd:cd05154     4 RRLSGGASNETYLVDAGGdgggrRLVLRRPPPGGLLPSAHDlerEY-RVLRALAGTGVPVPRVLALCEDPSVlgaPFYVM 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426  91 EYL----PPKPLDAHN---------AFLLGQQLARLHQwseqpqygLDYDNH--LSTTPQPNAWQR---RWASFFAEQRi 152
Cdd:cd05154    83 ERVdgrvLPDPLPRPDlspeerralARSLVDALAALHS--------VDPAALglADLGRPEGYLERqvdRWRRQLEAAA- 153
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426 153 gwqlelaaekgmefGDIDRIVDAVHQQLVSHQPA---PSLLHGDLWSGNCalgpdgpyIFDPA-----------CYWGDR 218
Cdd:cd05154   154 --------------TDPPPALEEALRWLRANLPAdgrPVLVHGDFRLGNL--------LFDPDgrvtavldwelATLGDP 211
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|.
gi 1349326426 219 ECDLAMLpLHPEQPPQIYDGYQSVLPLPaGFLERQPLYQLY 259
Cdd:cd05154   212 LEDLAWL-LARWWRPGDPPGLAAPTRLP-GFPSREELLARY 250
SrkA COG2334
Ser/Thr protein kinase RdoA involved in Cpx stress response, MazF antagonist [Signal ...
11-251 8.63e-07

Ser/Thr protein kinase RdoA involved in Cpx stress response, MazF antagonist [Signal transduction mechanisms]; Ser/Thr protein kinase RdoA involved in Cpx stress response, MazF antagonist is part of the Pathway/BioSystem: Threonine biosynthesis


Pssm-ID: 441905 [Multi-domain]  Cd Length: 297  Bit Score: 49.15  E-value: 8.63e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426  11 EQLGAGEISQRTELPGGEiHAAWRIDWAGRAIFV------KCDDSTLLPCFTAEADQLillaRSKTVTVPEVL------G 78
Cdd:COG2334     8 ERYGLGPLSSLKPLNSGE-NRNYRVETEDGRRYVlklyrpGRWSPEEIPFELALLAHL----AAAGLPVPAPVptrdgeT 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426  79 VGSDREYSFLLLEYLPPKPLDAHNA---FLLGQQLARLHQwseqpqygldydnHLSTTPQPNAWQRRWASFFAEQRIGWQ 155
Cdd:COG2334    83 LLELEGRPAALFPFLPGRSPEEPSPeqlEELGRLLARLHR-------------ALADFPRPNARDLAWWDELLERLLGPL 149
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426 156 LELAAEKGMefgdIDRIVDAVHQQLVSHQPA--PSLLHGDLWSGNCALGPDG-PYI--FDPACYwGDRECDLAML----P 226
Cdd:COG2334   150 LPDPEDRAL----LEELLDRLEARLAPLLGAlpRGVIHGDLHPDNVLFDGDGvSGLidFDDAGY-GPRLYDLAIAlngwA 224
                         250       260
                  ....*....|....*....|....*...
gi 1349326426 227 LHPEQPPQ---IYDGYQSVLPLPAGFLE 251
Cdd:COG2334   225 DGPLDPARlaaLLEGYRAVRPLTEAELA 252
APH cd05150
Aminoglycoside 3'-phosphotransferase; APH catalyzes the transfer of the gamma-phosphoryl group ...
33-114 2.23e-05

Aminoglycoside 3'-phosphotransferase; APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibiotics. The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K).


Pssm-ID: 270699 [Multi-domain]  Cd Length: 244  Bit Score: 44.88  E-value: 2.23e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426  33 WRIDWAGRAIFVKCDDSTLLPCFTAEADQLILLARskTVTVPEVLGVGSDREYSFLLLEYLPPKPLDAHNAF-------- 104
Cdd:cd05150    16 YRLDGGGPVLYLKTAPAGYAYELAREAERLRWLAG--KLPVPEVLDYGSDDGGDWLLTTALPGRDAASLEPLldperlvd 93
                          90
                  ....*....|
gi 1349326426 105 LLGQQLARLH 114
Cdd:cd05150    94 LLAEALRALH 103
CotS COG0510
Thiamine kinase or a related kinase [Coenzyme transport and metabolism];
157-247 7.09e-04

Thiamine kinase or a related kinase [Coenzyme transport and metabolism];


Pssm-ID: 440276 [Multi-domain]  Cd Length: 156  Bit Score: 39.38  E-value: 7.09e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1349326426 157 ELAAEKGMEFGDIDRIVDAVHQQLVSHQPAPSLLHGDLWSGNCALGPDG-PYIFDP--ACyWGDRECDLAML----PLHP 229
Cdd:COG0510    19 RYLALGPRDLPELLRRLEELERALAARPLPLVLCHGDLHPGNFLVTDDGrLYLIDWeyAG-LGDPAFDLAALlveyGLSP 97
                          90
                  ....*....|....*...
gi 1349326426 230 EQPPQIYDGYQSVLPLPA 247
Cdd:COG0510    98 EQAEELLEAYGFGRPTEE 115
ChoK-like cd05151
Choline Kinase and similar proteins; This subfamily is composed of bacterial and eukaryotic ...
157-225 8.35e-03

Choline Kinase and similar proteins; This subfamily is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate and displays negligible activity towards N-methylated derivatives of Etn. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K).


Pssm-ID: 270700 [Multi-domain]  Cd Length: 152  Bit Score: 35.99  E-value: 8.35e-03
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1349326426 157 ELAAEKGMEFGDIDRIVDAVHQ--QLVSHQPAPSllHGDLWSGNCALGPDGPYIFDpacyW-----GDRECDLAML 225
Cdd:cd05151    77 TLLTNDFSDPENLERIAALLRKlhSSPLEDLVLC--HNDLVPGNFLLDDDRLYLID----WeyagmNDPLFDLAAL 146
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH